Long Term Study of Canakinumab (ACZ885) in Patients With Gout

NCT00927810 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

341

Enrollment

INDUSTRY

Sponsor class

Conditions

Gouty Arthritis

Interventions

DRUG: Canakinumab

Sponsor

Novartis Pharmaceuticals